• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study' by Potere .

作者信息

Buckley Leo

机构信息

Department of Pharmacy Services, Brigham and Women's Hospital, Boston, MA, USA

出版信息

Ann Rheum Dis. 2022 Oct;81(10):e194. doi: 10.1136/annrheumdis-2020-218693. Epub 2020 Sep 1.

DOI:10.1136/annrheumdis-2020-218693
PMID:32873553
Abstract
摘要

相似文献

1
Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study' by Potere .关于Potere的“皮下注射托珠单抗阻断白细胞介素-6受体治疗重症新型冠状病毒肺炎和炎症反应过度：一项病例对照研究”的通信
Ann Rheum Dis. 2022 Oct;81(10):e194. doi: 10.1136/annrheumdis-2020-218693. Epub 2020 Sep 1.
2
Response to: 'Correspondence on 'Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study' by Potere by Buckley.
Ann Rheum Dis. 2022 Oct;81(10):e195. doi: 10.1136/annrheumdis-2020-218715. Epub 2020 Sep 1.
3
Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.关于“皮下注射托珠单抗阻断白细胞介素-6受体治疗重症新型冠状病毒肺炎和炎症反应过度：病例对照研究”的通信
Ann Rheum Dis. 2023 Aug;82(8):e182. doi: 10.1136/annrheumdis-2020-218836. Epub 2020 Sep 21.
4
Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study.皮下注射托珠单抗阻断白细胞介素-6受体治疗重症新型冠状病毒肺炎及炎症风暴：一项病例对照研究
Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218243. Epub 2020 Jul 9.
5
Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre .关于Della-Torre的“用萨瑞鲁单抗阻断白细胞介素-6治疗伴有全身炎症反应的重症COVID-19肺炎——一项开放标签队列研究”的通信
Ann Rheum Dis. 2022 Oct;81(10):e196. doi: 10.1136/annrheumdis-2020-218616. Epub 2020 Aug 19.
6
Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to: 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre ' by Cheng and Zhang.
Ann Rheum Dis. 2022 Oct;81(10):e197. doi: 10.1136/annrheumdis-2020-218724. Epub 2020 Aug 19.
7
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19.白细胞介素-6 受体阻滞剂托珠单抗皮下注射可改善 COVID-19 患者的凝血活性。
Eur J Intern Med. 2021 Jan;83:34-38. doi: 10.1016/j.ejim.2020.10.020. Epub 2020 Nov 3.
8
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia.托珠单抗治疗重症 COVID-19 肺炎住院患者。
N Engl J Med. 2021 Apr 22;384(16):1503-1516. doi: 10.1056/NEJMoa2028700. Epub 2021 Feb 25.
9
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.在重度新型冠状病毒肺炎和中度炎症反应患者中，单用皮质类固醇或联合托珠单抗治疗后使用阿那白滞素：一项回顾性队列研究：回复
Intern Emerg Med. 2021 Jun;16(4):1105-1106. doi: 10.1007/s11739-021-02690-3. Epub 2021 Mar 10.
10
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study.阿那白滞素治疗单独使用皮质类固醇激素或托珠单抗治疗重症 COVID-19 肺炎和中度炎症过度患者。一项回顾性队列研究。
Intern Emerg Med. 2021 Jun;16(4):843-852. doi: 10.1007/s11739-020-02600-z. Epub 2021 Jan 5.